Latest current assets for PLSE: $110M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Pulse Biosciences (PLSE) currently reports a current assets of $110M as of June 2026. That compares with $110M in the prior-year period — down 2.3% year over year. Use the charts on this page to explore Pulse Biosciences's current assets history and peer comparisons.
Pulse Biosciences's current assets decreased from $110M to $110M — a 2.3% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Pulse Biosciences reported $110M in current assets as of June 2026. That compares with $110M in the prior-year period — down 2.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current current assets of $110M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Pulse Biosciences, and consider following PLSE for alerts when major investors trade the stock.
Pulse Biosciences is classified in the Healthcare sector. On current assets, it currently shows $110M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing PLSE with unrelated industries.